ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 2 for:    journey heart failure turkey
Previous Study | Return to List | Next Study

Patient Journey in Hospital With Heart Failure in Turkish Population (JournayHF-TR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02487056
Recruitment Status : Completed
First Posted : July 1, 2015
Last Update Posted : August 22, 2016
Sponsor:
Information provided by (Responsible Party):
Prof. Dr. Mehdi Zoghi, Ege University

Brief Summary:
The purpose of this study is to compose a national database of the etiologies, clinical and demographic characteristics, using diagnostic tests, precipitating and risk factors, management of from intensive care unit or coronary care unit to hospital discharge, length of stay in the intensive care unit and hospital, in-hospital mortality and discharge medications of hospitalized acute heart failure patients in Turkish population.

Condition or disease
Heart Failure

Detailed Description:
The etiologies, precipitating factors, demographics, clinical characteristics, management and outcome of patients admitted in hospital with acute heart failure in Turkish population will be recorded.

Study Type : Observational
Actual Enrollment : 10606 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Multicentre, Prospective, Observational, Hospital-based Registry of Patients With Acute Heart Failure Those Whose Care Was Guided by a Cardiologist in Turkey
Study Start Date : September 2015
Actual Primary Completion Date : April 2016
Actual Study Completion Date : August 2016

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Management, etiology and outcomes of patients admitted of acute heart failure in Turkey [ Time Frame: During hospitalization ]
    Recording etiologies, precipitating factors, demographics, clinical characteristics, management and outcomes of patients admitted in hospital with acute heart failure.


Secondary Outcome Measures :
  1. Time to completion of last dose of any IV drugs that can be used for the treatment of acute Heat failure [ Time Frame: for the first 5 days following the start of the drug infusion ]
  2. Length of hospitalisation [ Time Frame: up to 30 days ]
  3. in-hospital mortality [ Time Frame: All cause of mortality ]
  4. To identify targets for the long term objectives of improving quality of care in acute heart failure patients from the Turkey [ Time Frame: 1 year ]
  5. Change from baseline in clinical, laboratory, hemodynamic parameters and drugs doses [ Time Frame: Durign hospitalisation ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Hospitalized patients with acute heart failure
Criteria

Inclusion Criteria:

  • Patients >18 years olds
  • Clinical diagnosis of acute heart failure
  • Admitted to the participating hospitals

Exclusion Criteria:

  • Patients <18 years old
  • Patients with acute heart failure who are discharged from the emergency room without admission.
  • Failure to obtain informed consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02487056


Locations
Turkey
Ahmet Ekmekçi
İstanbul, Turkey
Sponsors and Collaborators
Ege University
Investigators
Study Chair: Ahmet Ekmekçi, MD Dr. Siyami Ersek Göğüs Kalp Ve Damar Cerrahisi Eğitim Ve Araştırma Hastanesi

Responsible Party: Prof. Dr. Mehdi Zoghi, Prof. Dr., Ege University
ClinicalTrials.gov Identifier: NCT02487056     History of Changes
Other Study ID Numbers: JournayHF-TR
First Posted: July 1, 2015    Key Record Dates
Last Update Posted: August 22, 2016
Last Verified: September 2015

Keywords provided by Prof. Dr. Mehdi Zoghi, Ege University:
Heart Failure
Diagnosis
Management

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases